You are here
Aslan Pharma raises US$34m in fresh funding
THE Republic's fledgling pharma ecosystem on Monday got a shot in the arm as biotech startup Aslan Pharmaceuticals announced it has raised US$34 million in Series C funding led by Accuron Technologies, a tech subsidiary of Temasek Holdings.
The proceeds, said Aslan, will
- CALL +65 6388 3838
- EMAIL firstname.lastname@example.org